Annual report pursuant to Section 13 and 15(d)

Share-based Compensation (Tables)

v3.23.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Information about Incentive Plan

The following table contains information about the 2019 Plan as of December 31, 2022:

 

  Awards               Awards  
  Reserved for     Awards     Awards     Available for  
  Issuance     Issued     Exercised     Grant  
2019 Plan(1)     571,429       564,246       7,183       -  
Awards issued in excess of 2019 Plan     -       45,441       -       -  
Total     571,429       609,687       7,183       -  

 

(1) includes incentive stock options and restricted stock units discussed below.

Schedule of Incentive Stock Option Activity

The following table summarizes the Company’s incentive stock option activity and related information for the years ended December 31, 2022 and 2021.

 

          Weighted  
      Weighted     Average  
      Average     Contractual  
  Number of     Exercise     Term in  
    Options     Price     Years  
Outstanding at January 1, 2021     387,318     $ 1,124418       9.32  
Granted     90,478       3.960526       10.00  
Exercised     (7,183 )     1.75        
Forfeited                  
Cancelled     (28,571 )     1.40        
Expired     (7,103 )     1.75        
Outstanding at December 31, 2021     434,939     $ 1.678955       8.56  
                 
Granted     195,000     $ 3.3461538       10.00  
Exercised     —-              
Forfeited                  
Cancelled     (100,001 )     1.40000        
Expired     (5,001 )     1.40000        
Outstanding at December 31, 2022     524,937     $ 2.351416       8.38  
Exercisable at December 31, 2022     379,937     $ 1.777020       7.86  
Schedule of Assumptions used in Share-based Compensation

 

 

      2022     2021  
Volatility     277.84 %     171.12%-183.48 %
Risk-free interest rate     4.06 %     0.46% - 0.86 %
Dividend yield     0.0 %     0.0 %
Expected term     5.0 years       5.0-5.75 years  
Schedule of Restricted Stock Units Grant

 

      Weighted  
      Average  
  Number of     Grant Date  
  Units     Fair Value  
Outstanding at December 31, 2020     39,524     $ 2.10  
Granted            
Exercised and converted to common shares     (39,524 )     2.10  
Forfeited            
Outstanding at December 31, 2021            
Granted     96,114       1.61  
Exercised and converted to common shares     (5,682 )     4.40  
Forfeited            
Outstanding at December 31, 2022     90,432     $ 1.43  
Exercisable at December 31, 2022     5,682     $ 4.40  
Summary of Common Stock Warrants

The following table shows a summary of common stock warrants for the years ended December 31, 2022 and 2021.

 

      Weighted     Weighted  
      Average     Average  
  Number of     Exercise     Contractual  
  Warrants     Price     Term in Years  
Outstanding at December 31, 2020     210,500     $ 0.85938       2.54  
                 
Granted     3,426,690     $ 5.42717       4.98  
Exercised                  
Forfeited                  
Cancelled                  
Expired                  
Outstanding at December 31, 2021     3,637,190     $ 5.16281       4.63  
Granted                  
Exercised                  
Forfeited                  
Cancelled                  
Expired                  
Outstanding at December 31, 2022     3,637,190     $ 5.16281       3.65  
Exercisable at December 31, 2022     3,637,190     $ 5.16281       3.65